Prepare for your visit
Gary Madden
Obstetrics & Gynecology · Midland, TX · NPI 1386757136
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,314.75
in general payments reported to CMS, 2019-2025 · $244 in 2025
The $244 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $824.56
- Bayer Healthcare Pharmaceuticals INC. $343.16
- Amgen INC. $298.59
- Astellas Pharma US INC $283.24
- Radius Health, INC. $147.93
- Daiichi Sankyo INC. $127.95
Drugs and devices associated with these payments
Tymlos Veozah Monoferric Zurzuvae Myfembree Injectafer Zepbound Qulipta Myosure Tissue Removal Device Jada System Evenity Prolia
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Gary Madden listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/198395/gary-madden